Investor Presentation • Jul 26, 2021
Investor Presentation
Open in ViewerOpens in native device viewer
G-LAB FAMILY FROM THE GESTAMP´S G-LAB PROGRAM
July 26th, 2021
This presentation has been prepared solely for use at this presentation of our results as of and for the first half ended June 30th , 2021. By attending the conference call meeting where this presentation is made, or by reading the presentation slides, you agree to be bound by the following limitations.
This presentation is not an offer for sale of securities in the United States or in any other jurisdiction. This presentation has been prepared for information and background purposes only. It is confidential and does not constitute or form part of, and should not be construed as, an offer or invitation to subscribe for, underwrite or otherwise acquire, any securities of Gestamp Automociόn, S.A. (the "Company") or any member of its group nor should it or any part of it form the basis of, or be relied on in connection with, any contract to purchase or subscribe for any securities of the Company or any member of its group or with any other contract or commitment whatsoever. Neither this presentation nor any part of it may be reproduced (electronically or otherwise) or redistributed, passed on, or the contents otherwise divulged, directly or indirectly, to any other person or published in whole or in part for any purpose without the prior written consent of the Company.
This presentation does not purport to be all-inclusive or to contain all of the information that any person may require to make a full analysis of the matters referred to herein. Each recipient of this presentation must make its own independent investigation and analysis of the Company.
This presentation may contain certain forward-looking statements and judgements that reflect the management's intentions, beliefs or current expectations. These forward-looking statements include, but are not limited to, all statements other than statements of historical facts, including, without, limitation, those regarding the Company's future financial position and results of operations, strategy, plans, objectives, goals and targets and future developments in the markets where the Company participates or is seeking to participate. The Company's ability to achieve its projected results is dependent on many factors which are outside management's control. Actual results may differ materially from (and be more negative than) those projected or implied in the forward-looking statements. Such forward-looking information involves risks and uncertainties that could significantly affect expected results and is based on certain key assumptions. Due to such uncertainties and risks, readers are cautioned not to place undue reliance on such forward-looking statements as a prediction of actual results. All forward-looking statements included herein are based on information available to the Company as of the date hereof. The Company undertakes no obligation to update publicly or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as may be required by applicable law. All subsequent written and oral forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these cautionary statements. Growth at constant exchange rates is a numerical translation of our figures from local currencies to euros, and not a description of the situation if the currencies had not moved. Capex split in categories is a management judgement, and should not be considered as a substitute for additions of tangible and intangible assets, nor depreciation and amortization.
In this presentation, we may rely on and refer to information regarding our business and the market in which we operate and compete. We have obtained this information from various third party sources, including providers of industry data, discussions with our customers and our own internal estimates. We cannot assure you that any of this information is accurate or correctly reflects our position in the industry, and none of our internal surveys or information has been verified by any independent sources.
No representation or warranty, express or implied, is made as to the fairness, accuracy or completeness of the information contained herein. None of the Company, its advisers, connected persons or any other person accepts any liability for any loss howsoever arising, directly or indirectly, from this presentation or its contents. This shall not, however, restrict or exclude or limit any duty or liability to a person under any applicable laws or regulations of any jurisdiction which may not lawfully be disclaimed (including in relation to fraudulent misrepresentation).
Financial Overview
Outlook and Remarks
Solid results in H1 despite a more complex volume momentum in Q2 due to the semiconductors shortage impact

(1) Measured at constant FX for comparability reasons and based on IHS data as of July 2021 (2) Free Cash Flow excludes dividends, share repurchases as well as potential M&A items
| (In million Euros – excl. TP) |
H1 2020 | H1 2021 |
|---|---|---|
| Total Revenue | 3,045 | 4,076 |
| EBITDA | 216 | 498 |
| EBITDA margin (%) | 7.1% | 12.2% |
| EBIT | -87 | 208 |
| EBIT margin (%) | -2.9% | 5.1% |
| Net Income | -120 | 83 |
| Capex (excl. IFRS 16) |
257 | 212 |
| Net debt (excl. IFRS 16) |
2,652 | 2,066 |
| Operating Leases (IFRS 16) | 386 | 414 |
| H1 2021 Revenue increased by 40.3% at constant FX and |
EBITDA improved by 143.4% at constant FX
Note: Reported Revenue increase of 33.8% and EBITDA increase of 130.7%
| (In million Euros – excl. TP) |
Q2 2020 | Q2 2021 |
|---|---|---|
| Total Revenue | 1,034 | 1,967 |
| EBITDA | 23 | 240 |
| EBITDA margin (%) | 2.3% | 12.2% |
| EBIT | -130 | 96 |
| EBIT margin (%) | -12.6% | 4.9% |
| Net Income | -134 | 32 |
| Capex (excl. IFRS 16) |
111 | 102 |
Q2 2021 Revenue increased by 95.9% at constant FX and EBITDA improved by 965.7% at constant FX
Note: Reported Revenue increase of 90.3% and EBITDA increase of 928.3%
Gestamp Revenue Growth at Constant FX vs. Market Production Growth in Gestamp Markets

Note: Gestamp's growth at constant FX used for comparability with production volumes. Market production volume growth is based on countries in Gestamp's production footprint (IHS data for H1 2021 as of July 2021). Western Europe data includes Morocco in line with our reporting. 1. Market and Gestamp weighted growth measured with H1 2020 geographical weights as a base
Quarterly forecast - Supply Chain Disruptions – Semiconductors
Global Light Vehicle production volumes in Q2 21 were -15.1% below those of Q2 19, but +48.6% above Q2 20, which was heavily impacted by the pandemic
IHS quantifies the volumes lost in -1.44 Mveh for Q1 and -2.59 Mveh for Q2, and forecasts -0.86 Mveh in Q3 due to the semiconductor shortages

Source: IHS Production as of July 2021. 2021 figures are susceptible to change / Semiconductor impact IHS version of July 16th




Source: 1) IHS as of July 2021 and 2) US Bureau of Labor Statistics
© Gestamp 2021 9

Note: Gross Margin calculated as Revenues minus Raw Materials. 2020 levels affected by Covid-19 impact


Note: EBITDA Margin and Net Income excluding Transformation Plan impact in Q2 2020
Key Highlights for H1 2021
Financial Overview
Outlook and Remarks
| Revenues (€m) | EBITDA (€m) | EBITDA Margin (%) | ||
|---|---|---|---|---|
| H1 20 H1 21 Var. (%) |
H1 20 H1 21 Var. (%) |
H1 2020 H1 2021 |
||
| Western Europe | 1,332 1,810 35.9 % |
64 193 198.9 % |
4.8% 10.6% |
|
| Outperformance: +9.6 p.p. Performance at constant FX: +198.6 % |
||||
| Eastern Europe | 478 640 33.8 % |
64 105 65.1 % |
13.3% 16.4% |
|
| Outperformance: +14.7 p.p. | Performance at constant FX: +86.0 % | |||
| NAFTA | 665 890 33.9 % |
44 105 136.6 % |
6.7% 11.8% |
|
| Outperformance: +8.8 p.p. | Performance at constant FX: +152.2 % | |||
| Mercosur | 143 221 55.2 % |
-7 24 n.m. |
-5.0% 10.8% |
|
| Outperformance: +34.1 p.p. | Performance at constant FX: n.m. | |||
| Asia | 428 515 20.3 % |
51 72 41.3 % |
||
| Underperformance: -4.2 p.p. | Performance at constant FX: +44.4 % | 11.8% 13.9% |
||
| 3,045 4,076 33.8 % |
216 498 130.7 % |
|||
| Outperformance: +10.8 p.p. | Performance at constant FX: +143.4 % | 7.1% 12.2% |
Note: Gestamp's growth at constant FX used for comparability with production volumes. Market production volume growth based on countries in Gestamp's production footprint (IHS data as of July 2021). W. Europe data includes Morocco in line with our reporting. Outperformance calculated on a constant FX basis.

Note: Capex incl. IFRS 16 in H1 2021 amounted to €219m
(1) Growth capex defined as capital expenditure on greenfield property, plant & equipment, major plant expansions and new customer products/technologies
(In million Euros)

(1) Net cash capex investments
(2) Other non-cash items include change in provisions, grants related to income, gains and losses from asset disposals, unrealized exchange rate differences and other income and expenses
(3) Free Cash Flow excludes dividends, share repurchases as well as potential M&A items
(4) Free Cash Flow generation assuming FY 2020 factoring levels of €633m
(In €m)
| H1 2020 | FY 2020 | H1 2021 | |
|---|---|---|---|
| Net Debt (excl. IFRS 16) |
2,652 | 2,058 | 2,066 |
| Operating Leases (IFRS 16) |
386 | 427 | 414 |
| Net Debt (incl. IFRS 16) |
3,037 | 2,485 | 2,480 |
| ND/EBITDA (excl. IFRS 16) (1) | 3.9x | 3.1x | 2.2x |

Note: Net Debt / EBITDA calculated by excluding the Transformation Plan at EBITDA level in 2020 (no impact in Q1) but including its cash impact at net debt (1) Excluding IFRS 16 and the impact of the Transformation Plan

| 3 | |
|---|---|
1 Partial acquisition of minorities in China (Cofides)
2 Enhancing net profit Investment of €26m outlaid in Q2 2021
Further repurchases to be carried out
China key growth area within our strategy
Use of liquidity resources
Key Highlights for H1 2021
Financial Overview
Outlook and Remarks
| Former Guidance 2021 | Revised Guidance 2021 | |
|---|---|---|
| Revenues | Mid-single digit outperformance to the market |
Mid-single digit outperformance to the market |
| EBITDA margin | EBITDA margin >12% | EBITDA margin >12% |
| Capex (1) | ~ 7% of revenues | < 6.5% of revenues |
| Net Debt (1) (2) | < €2 bn | > €100m reduction vs. FY 2020 |
Focus on increasing profitability and FCF generation as a key priority
Note: On a constant FX basis. Excluding the systemic effect of coronavirus. (1) Excluding IFRS 16. and (2) Net Debt excl. IFRS 16 as of FY 2020 of €2,058m
© Gestamp 2021 19

Note: (1) On a constant FX basis
Investor Relations
© Gestamp 2021 21
+34 91 275 28 72
www.gestamp.com

Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.